Shanghai Kaibao Pharmaceutical CO.,Ltd held its 1st Extraordinary General Meeting of 2023 on 22 December 2023, during which the following proposal(s) was/were approved: Election and nomination of non-independent directors, cumulative voting system applicable, Mu Jingwei, non-independent director: Zhou Yingbin, non-independent director, Jing Shuzhong, non-independent director, Liu Jianzhong, non-independent director, Ren Liwang, non-independent director, Zhao Ningbo, non-independent director. Election and nomination of independent directors, cumulative voting system applicable: Ye Zuguang, independent director, Li Zhenni, independent director, Ma Hong, independent director.